Stanford Seminar: A Tearful Tale of Biodesign
758 views · Published 6 December 2016 · 54:02 · Indexed 24 October 2026
Channel: Stanford Online · 2016 · Education
Michael Ackermann Vice-President of Neuro-Simulation of Allergan Michael Ackermann, CEO of a med-tech startup that created a tear-stimulation device for those with dry-eye disease, explains how acquisition by a global pharmaceutical giant is helping him achieve his goal of reaching as many patients as possible. Ackermann, a graduate of the Stanford Byers Center for Biodesign, also discusses why big tech companies have yet to disrupt healthcare and how that translates into big opportunities for entrepreneurs. Michael Ackermann is vice president of neuro-stimulation for Allergan, a $23 billion global pharmaceutical company and a leader in a new industry model called “growth pharma.” He previously served as CEO of Oculeve, Inc., which developed tear-stimulation devices and was acquired by Allergan in August 2015. Ackermann co-founded Oculeve while in the Stanford biodesign fellowship, and spun it out of the university in 2012. Learn more about Stanford's eCorner: https://ecorner.stanford.edu Learn more about Stanford's online classes and certificates: https://online.stanford.edu/programs See the full playlist: https://www.youtube.com/playlist?list=PLoROMvodv4rPE-kcGtKBgYtSMqEJKbESC
More from this channel
-
7:24
A Conversation About Energy, Ricardo Levy and Howie Rosen
-
9:42
Entrepreneurship in Engineering and Science-Based Industries
-
1:02:58
Graduate Student Orientation - September 2012
-
1:11:55
Stanford Seminar - Rex Northen on Cleantech
-
1:09:19
Stanford Seminar - Richard Dasher on Green Transportation
-
1:18:41
Stanford Seminar - Osamu Onodera on Green Transportation in Japan
-
1:14:39
Stanford Seminar - Green Building and LEED for Homes
-
1:10:18
Stanford Seminar - Hiroshi Shimizu on Electric Vehicle Technology